Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
760.50    7.50 (1.00%)
Bid:
759.50
Ask:
760.50
Spread: 1.00 (0.132%)
Market Cap: £2.56b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Offer Lapsed

30 May 2025 07:00

RNS Number : 6813K
Drax Group PLC
30 May 2025
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

Β 

FOR IMMEDIATE RELEASE

Β 

Β 

30 May 2025

Β 

Β 

DRAX BESS HOLDCO LIMITED ("DRAX BIDCO")

Β 

Lapse of Drax Bidco's offer for HEIT

Further to the announcement made by Drax Bidco, a wholly-owned subsidiary undertaking of Drax Group plc, on 20 May 2025, Drax Bidco today confirms that its cash offer for the entire issued share capital of HEIT (the "Acquisition" or the "Drax Offer") has lapsed.

On 25 March 2025, the boards of directors of Drax Bidco and HEIT made an announcement pursuant to Rule 2.7 of the Code that they had reached agreement on the terms of the Drax Offer, to be implemented by way of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Drax Scheme").

The Drax Scheme was conditional, amongst other things, on Drax Bidco's Court Meeting being held on or before the 22nd day after 7 May 2025, being the originally expected date of the Court Meeting (or such later date as may be agreed by Drax Bidco and HEIT with the consent of the Panel and, if required that the Court may allow) (the "Mini Long Stop Date"). No such later date was agreed between Drax Bidco and HEIT and the Mini Long Stop Date therefore was 29 May 2025.

Condition 2(a)(ii), as set out in the Drax Scheme, was not satisfied on or before 29 May 2025. Drax Bidco has invoked the Mini Long Stop Date condition of the Drax Scheme and, as such, the Drax Scheme has lapsed, with effect from this announcement.

This announcement should be read in conjunction with the scheme document published or otherwise made available to HEIT Shareholders on 15 April 2025 (the "Scheme Document"). Capitalised terms in this announcement, unless otherwise defined have the same meanings as set out in Part X of the Scheme Document.

Β 

Enquiries:

Β 

Drax and Drax Bidco

Β 

Enquiries:

Drax Investor Relations:

Mark Strafford

mark.strafford@drax.com

+44 (0) 7730 763 949

Β 

Chris Simpson

Chris.Simpson@drax.com

+44 (0) 7923 257 815

Β 

Media:

Drax External Communications:

Chris Mostyn

Chris.Mostyn@drax.com

+44 (0) 7743 963 483

Β 

J.P. Morgan Cazenove (Financial Adviser and Corporate Broker to Drax and Drax Bidco)

+44 (0) 2034 938 000

Robert Constant

James Robinson

Alia Malik

Rupert Budge

Edward Hatter

Β 

Important notices

Β 

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the PRA and regulated in the United Kingdom by the PRA and the FCA. J.P. Morgan Cazenove is acting as financial adviser exclusively for Drax Bidco and Drax and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Drax Bidco and Drax for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

Β 

Further information

Β 

This announcement is for information purposes only and is not intended to and does not constitute, or form part of, an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, pursuant to the Acquisition or otherwise, nor shall there be any purchase, sale, issuance or exchange of securities or such solicitation in any jurisdiction in which such offer, invitation, solicitation, purchase, sale, issuance or exchange is unlawful.

Β 

This announcement has been prepared for the purpose of complying with English law, the Code, and the Disclosure Guidance and Transparency Rules, and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside England and Wales. The Acquisition will be subject to the applicable requirements of the Code, the Panel, the London Stock Exchange and the Financial Conduct Authority.

Β 

This announcement does not constitute a prospectus or prospectus exempted document.

The release, publication or distribution of this announcement in or into certain jurisdictions other than the United Kingdom may be restricted by law. Persons who are not resident in the United Kingdom or who are subject to other jurisdictions should inform themselves of, and observe, any applicable requirements.

If you are in any doubt about the contents of this announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor or independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom or, if not, from another appropriate authorised independent financial adviser.

Β 

Publication on website and availability of hard copies

Β 

A copy of this announcement will be made available, free of charge, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Drax's website at www.drax.com/investors/offer. For the avoidance of doubt, the contents of this website is not incorporated into and do not form part of this announcement.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
OLABLGDUGDDDGUC
Date   Source Headline
1st Nov 20221:26 pmRNSTotal Voting Rights
28th Oct 20229:00 amRNSAdditional Listing
12th Oct 20227:19 amRNSTemporary Cost-Plus Revenue Limit and CfD
3rd Oct 20221:38 pmRNSBlock listing Interim Review - SAYE
3rd Oct 20221:36 pmRNSBlock listing Interim Review - PSP
3rd Oct 20221:36 pmRNSBlock listing Interim Review - LTIP 2020
3rd Oct 20221:31 pmRNSBlock listing Interim Review - DSP
3rd Oct 20221:22 pmRNSTotal Voting Rights
3rd Oct 20227:00 amRNSAcquisition of Remaining Interest in Pellet JV
29th Sep 20229:00 amRNSAdditional Listing
13th Sep 20229:35 amRNSTotal Voting Rights
23rd Aug 20229:40 amRNSAdditional Listing
3rd Aug 20224:00 pmRNSAcquisition of 90,000 tonnes Canadian pellet plant
1st Aug 202211:46 amRNSTotal Voting Rights
26th Jul 20227:00 amRNSHalf-year Report
20th Jul 202211:43 amRNSNotice of Results
15th Jul 20224:48 pmRNSHolding(s) in Company
6th Jul 20225:46 pmRNSUpdated expectations for full year 2022
6th Jul 20225:41 pmRNSExtension of coal operations at request of UK Gov
1st Jul 202210:43 amRNSTotal Voting Rights
28th Jun 202211:30 amRNSNotice of Change to Director Details
6th Jun 20223:01 pmRNSTotal Voting Rights
17th May 202211:34 amRNSHolding(s) in Company
12th May 20229:00 amRNSAdditional Listing
4th May 202211:03 amRNSDirector/PDMR Shareholding
3rd May 20225:03 pmRNSTotal Voting Rights
27th Apr 20223:19 pmRNSResult of AGM
27th Apr 20227:00 amRNSTrading Update
26th Apr 202212:20 pmRNSHolding(s) in Company
19th Apr 202212:00 pmRNS2022 Performance Awards - EPS Condition
8th Apr 202211:13 amRNSBlock listing Interim Review - SAYE
8th Apr 202211:11 amRNSBlock listing Interim Review - PSP
8th Apr 202211:10 amRNSBlock listing Interim Review - LTIP 2020
8th Apr 202211:08 amRNSBlock listing Interim Review - DSP
6th Apr 20223:30 pmRNSDirector/PDMR Shareholding
6th Apr 20229:00 amRNSTotal Voting Rights
30th Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:00 amRNSDirector/PDMR Shareholding
17th Mar 20221:34 pmRNSMailing of Annual Report and Notice of AGM
16th Mar 20229:00 amRNSAdditional Listing
1st Mar 202212:39 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSAnnual Financial Report
23rd Feb 20229:00 amRNSCapacity Market Agreements
16th Feb 20222:40 pmRNSNotice of Results
7th Feb 20228:30 amRNSAdditional Listing
2nd Feb 20229:27 amRNSTotal Voting Rights
28th Jan 202212:25 pmRNSResult of audit tender
5th Jan 20228:30 amRNSAdditional Listing
4th Jan 20223:49 pmRNSTotal Voting Rights
22nd Dec 20213:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.